Key Account Manager
Mirum Pharmaceuticals
Key Account Manager
Mirum Pharmaceuticals
ASBT inhibitors for rare liver diseases
MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Key Account Manager (KAM)contributes to Mirum’s mission by helping improve awareness, access and support for patients living with rare liver diseases across the assigned region in Germany. This is a field-based commercial professional responsible for developing and growing Mirum’s hepatology disease portfolio within an assigned territory in Germany.
While working in close partnership with healthcare professionals and multidisciplinary care teams, the KAM develops and executes strategic account plans for priority centers and regional networks that support appropriate patient identification, access and use of Mirum’s therapies. The KAM combines strong clinical knowledge with commercial excellence to build trusted customer relationships, identify opportunities and support long-term account development. These roles work collaboratively with Medical Affairs, Market Access, Marketing and other cross-functional partners and translates customer insights into effective account strategies while ensuring all activities comply with applicable legal, regulatory and company requirements.
KEY RESPONSIBILITIES
QUALIFICATIONS & REQUIREMENTS
KEY COMPETENCIES
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
ASBT inhibitors for rare liver diseases
Mirum develops therapies for rare liver diseases, led by LIVMARLI (maralixibat), an oral ASBT inhibitor that reduces bile acid buildup and itching in Alagille syndrome and other cholestatic conditions. It is pursuing LIVMARLI for additional rare diseases such as PFIC and biliary atresia and developing volixibat for primary sclerosing cholangitis and primary biliary cholangitis. The company combines drug development with commercialization in the United States and other major markets, working with physicians, payers, and patient groups to improve access. Its goal is to bring effective therapies to patients with rare liver diseases and build a sustainable commercial presence in key markets.
Explore more opportunities at Mirum Pharmaceuticals